课题基金 / 基金详情

Classification of Substance Use Severity and Treatment Outcomes: NIDA CTN Studies

Classification of Substance Use Severity and Treatment Outcomes: NIDA CTN Studies
物质使用严重程度和治疗结果的分类:NIDA CTN 研究
批准号:
8311820
负责人:
Li-Tzy Wu
金额:
$35.51万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2009
资助国家:
美国
项目状态:
已结题
起止时间:
2009-09-01 至 2015-08-31

项目摘要

项目成果

Li-Tzy Wu的其他基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
ABSTRACT This R21/R33 application is in response to RFA-DA-09-020. It seeks support to address one research area recommended by this RFA ¿Secondary data analyses of multiple trials in the NIDA Clinical Trials Network (CTN).¿ By capitalizing on the CTN¿s wealth of multisite treatment data from multiple trials, we seek to, in the R21 phase (Year 1), 1) identify and create analyzable flat data files from the raw trial data (stacked format), 2) generate study variables and codebooks by programming scoring algorithms for multiple standardized clinical instruments, 3) evaluate the extent of missing data, and 4) examine baseline clinical profiles (substance use and diagnoses, mental health, and quality of life) of trial participants by gender and race/ethnicity in order to guide the R33 phase of work. In the R33 phase (Years 2-4), we plan to evaluate the construct, concurrent, and predictive validity of categorical and dimensional models of substance use diagnoses. The multisite CTN trials present an unparalleled, excellent opportunity to explore and evaluate these clinically and scientifically important issues directly related to treatment outcomes and to the emerging Diagnostic and Statistical Manual Version-IV (DSM-V). Study Aims for R33 are to 1) investigate measurement equivalence of DSM-IV diagnostic questions by gender and race/ethnicity, 2) evaluate the construct and concurrent validity of DSM-IV substance use diagnoses using categorical, dimensional, and integrated hybrid models of diagnostic classification, 3) determine empirically defined drug dependence subtypes (an integrated hybrid model) in predicting subsequent outcomes and to explore the mediator and moderators of the associations, and 4) evaluate empirically-defined comorbid drug dependence subtypes in predicting subsequent outcomes and to explore the mediator and moderators of the associations. Gender/sex differences will be examined in all analyses either through stratified analyses or the inclusions of interaction terms as appropriate.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Increasing access to opioid use disorder treatment by opening pharmacy-based medication units of opioid treatment programs
  • 批准号:
    10679104
  • 项目类别:
  • 资助金额:
    $71.83万
  • 财政年份:
    2022
  • 负责人:
    Li-Tzy Wu
  • 依托单位:
The impact of chronic pain on buprenorphine treatment retention among patients with opioid use disorder.
  • 批准号:
    10202541
  • 项目类别:
  • 资助金额:
    $8.05万
  • 财政年份:
    2020
  • 负责人:
    Li-Tzy Wu
  • 依托单位:
Substance Abuse & Treatment Gaps in Asians, Pacific Islanders & Multiple-race Ind
  • 批准号:
    8476963
  • 项目类别:
  • 资助金额:
    $39.25万
  • 财政年份:
    2013
  • 负责人:
    Li-Tzy Wu
  • 依托单位:
Substance Abuse & Treatment Gaps in Asians, Pacific Islanders & Multiple-race Ind
  • 批准号:
    8695479
  • 项目类别:
  • 资助金额:
    $39.25万
  • 财政年份:
    2013
  • 负责人:
    Li-Tzy Wu
  • 依托单位: